Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qilu Pharmaceutical is a leading vertically integrated pharmaceutical company based in China, specializing in the development, manufacturing, and marketing of generic and innovative drugs. The Qilu Clinical Research and Development Center serves as the core engine for the group's clinical advancement, focusing on high-end generics, biosimilars, and novel biologics. The company maintains a robust pipeline across oncology, cardiovascular, and anti-infective therapeutic areas. With a global footprint, Qilu exports products to over 70 countries and operates multiple R&D sites worldwide, including hubs in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qilu Clinical Research and Development Center.